FIELD: pharmacology.
SUBSTANCE: invention represents a medicinal form of a non-coated pill containing α,α,α-trifluorothymidine and hydrochloride 5-chloro-6-(2-iminopyrrolidine-1-yl)methyl-2,4(1N,3N)pyrimidinedione as active ingredients and, as such, not containing additives, including salt metals. The invention also includes a method for stabilization of an oral pharmaceutical composition containing the active ingredients described above.
EFFECT: increased stability of the medicinal form.
11 cl, 18 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ORAL ADMINISTRABLE PHARMACEUTICAL COMPOSITION | 2013 |
|
RU2600831C2 |
| ANTICANCER MEDICINE, CONTAINING α,α,α-TRIFLUOROTHYMIDINE AND THYMIDINE PHOSPHORYLASE INHIBITOR | 2006 |
|
RU2394581C2 |
| METHOD OF TREATING PATIENTS WITH CANCER WITH SEVERE RENAL INSUFFICIENCY | 2017 |
|
RU2727598C2 |
| PREPARATION POTENTIATING RADIATION THERAPY | 2007 |
|
RU2435587C2 |
| COMBINATION OF TRIFLURIDINE/TIPIRACIL HYDROCHLORIDE, ANTITUMOR PLATINUM COMPLEX, AND MODULATOR OF CONTROL POINTS OF IMMUNE RESPONSE | 2018 |
|
RU2778887C2 |
| PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2470637C2 |
| PHARMACEUTICAL COMPOSITION OF MOXIFLOXACIN AND METHOD FOR PRODUCING IT | 2014 |
|
RU2558932C1 |
| PHARMACEUTICAL ANTI-DIABETIC COMPOSITION BASED ON SUBSTITUTED THIOPHENE CARBOXYLATE AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2688235C1 |
| TABLET CONTAINING 5-HYDROXY-1H-IMIDAZOLE-4-CARBOXAMIDE | 2014 |
|
RU2654703C2 |
| PHARMACEUTICAL COMPOSITION INCLUDING SODIUM ALKYL SULPHATE | 2019 |
|
RU2759746C1 |
